Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2021-09-27 to 2026-11-09
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$170M
across 2 rounds
CO-INVESTORS
24
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2021-09-27 to 2026-11-09
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Delix Therapeutics A clinical-stage neuroscience company pioneering the discovery and development of neuroplastogens | Series C Verified against 1 of 2 sources | $100M | 2026-11-09 | [ PART ] |
Delix Therapeutics A clinical-stage neuroscience company pioneering the discovery and development of neuroplastogens | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $70M | 2021-09-27 | [ PART ] |